Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
81,000
Employees81,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
81,000
Employees81,000

PFE Key Statistics

Market cap
140.35B
Market cap140.35B
Price-Earnings ratio
13.15
Price-Earnings ratio13.15
Dividend yield
6.92%
Dividend yield6.92%
Average volume
44.43M
Average volume44.43M
High today
$24.80
High today$24.80
Low today
$24.51
Low today$24.51
Open price
$24.74
Open price$24.74
Volume
34.22M
Volume34.22M
52 Week high
$29.17
52 Week high$29.17
52 Week low
$20.92
52 Week low$20.92

PFE News

Nasdaq 16h
December 5th Options Now Available For Pfizer

Investors in Pfizer Inc (Symbol: PFE) saw new options begin trading today, for the December 5th expiration. At Stock Options Channel , our YieldBoost formula ha...

December 5th Options Now Available For Pfizer
The Motley Fool 18h
Investment Firm Verity & Verity Loads Up With 908,000 Pfizer Shares Worth $22.4 Million

Verity & Verity, LLC disclosed in its Oct. 21, 2025, SEC filing a purchase of 907,855 shares of Pfizer Inc. valued at an estimated $22.41 million for the quarte...

Investment Firm Verity & Verity Loads Up With 908,000 Pfizer Shares Worth $22.4 Million
TipRanks 21h
Pfizer’s Growth Outlook: Hold Rating Amid Declining Revenue and Uncertain Prospects

Bank of America Securities analyst Tim Anderson reiterated a Hold rating on Pfizer yesterday and set a price target of $30.00. Elevate Your Investing Strategy:...

Analyst ratings

60%

of 25 ratings
Buy
36%
Hold
60%
Sell
4%

More PFE News

24/7 Wall St. 2d
Pfizer and Verizon Offer 7% Yields With Lower Volatility Than S&P 500

Home Investing 2 Safer High-Yield Stocks That Can Pay Boomers for Life Investing 2 Safer High-Yield Stocks That Can Pay Boomers for Life By Joey Frenette Oct...

Pfizer and Verizon Offer 7% Yields With Lower Volatility Than S&P 500
TipRanks 2d
Notable open interest changes for October 22nd

Tuesday’s total option volume of 61.4 million contracts resulted in net open interest growth of 8.05 million calls and 6.57 million puts. Beyond Meat (BYND), NV...

Simply Wall St 2d
Does the Recent 3% Gain Signal a Turning Point for Pfizer Shares?

Thinking about what to do with Pfizer stock right now? You’re not alone, and frankly, it’s been a fascinating ride. After lagging for much of the past three yea...

Does the Recent 3% Gain Signal a Turning Point for Pfizer Shares?
Nasdaq 4d
Pfizer: XTANDI Plus Leuprolide Cuts Death Risk 40% In High-Risk NmHSPC Phase 3 Study

(RTTNews) - Pfizer Inc. (PFE) and Astellas Pharma U.S. Inc. announced final overall survival results from the Phase 3 EMBARK study evaluating XTANDI (enzalutami...

Pfizer: XTANDI Plus Leuprolide Cuts Death Risk 40% In High-Risk NmHSPC Phase 3 Study
TipRanks 4d
Astellas, Pfizer announces results from Phase 3 EV-303 trial for PADCEV

Astellas Pharma (ALPMY) and Pfizer (PFE) announced positive results from the Phase 3 EV-303 clinical trial for PADCEV, a Nectin-4 directed antibody-drug conjuga...

Investor's Business Daily 6d
Pfizer, Merck And Astellas Have An 'Enormous New Hope' For Bladder Cancer Patients

Pharma titans Merck (MRK), Pfizer (PFE) and Astellas Pharma (ALPMY) are delivering an "enormous new hope" for patients with an aggressive form of bladder cancer...

Pfizer, Merck And Astellas Have An 'Enormous New Hope' For Bladder Cancer Patients
TipRanks 6d
Metsera, Inc. Announces Special Meeting for Merger Vote with Pfizer

New activity is brewing for Metsera, Inc. ( (MTSR) ). The company has submitted a Form DEFM14A to the SEC, indicating an upcoming shareholder vote. This form gi...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.